P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder

Mauricio Tohen; Eduard Vieta; Julia Amsterdam; Scott T. Aaronson; Bin Sun; Charles L. Bowden; Michael Banov; Anantha Shekhar; Heather S. Oliff; L. Kryzhanovskaya

doi:10.1016/s0924-977x(07)70577-1

Related publications

Article2008

Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania

Mauricio Tohen, Eduard Vieta, Guy M. Goodwin, Bin Sun, Jay D. Amsterdam, Michael Banov, Anantha Shekhar, Scott T. Aaronson, L. M. Bardenstein, I Grecu-Gaboş, В А Точилов, Dan Prelipceanu, Heather S. Oliff, Ludmila Kryzhanovskaya, Charles L. Bowden

Article2009

P.3.c.061 Maintenance treatment with quetiapine added to either lithium or divalproex in bipolar I disorder

Trisha Suppes, Eduard Vieta, U. Gustafsson, Björn Paulsson

Article2014

P.2.d.002 Risk factors for rapid cycling in bipolar disorder

Marc Valentí Ribas, Isabella Pacchiarotti, Juan Undurraga, Caterina del Mar Bonnín, Dina Popović, Carla Torrent, Diego Hidalgo, Francesc Colom, Eduard Vieta

Article2011

P.2.e.002 Risk factors for antidepressant-related switch to mania

Marc Valentí, Isabella Pacchiarotti, Caterina del Mar Bonnín, Adriane Ribeiro Rosa, Dina Popović, Alessandra Nivoli, José Manuel Goikolea, Andréa Murru, Francesc Colom, Eduard Vieta

Article2007

P.3.c.058 Efficacy and safety of quetiapine in combination with lithium/divalproex as maintenance treatment for bipolar I disorder

Eduard Vieta, Ivan Eggens, Inger Persson, Björn Paulsson, Martin Brecher